Methylprednisolone and Appetite - increased - a phase IV clinical study of FDA data

Summary:

Appetite - increased is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Appetite - increased when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Appetite - increased?

Appetite - increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires) is found to be associated with 1,617 drugs and 2,023 conditions by eHealthMe. Check the latest studies of Appetite - increased.



On Jul, 09, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 89 people (0.15%) have Appetite - increased.

Could Methylprednisolone cause Appetite - increased?

Among these 89 people:

How long have people been on Methylprednisolone when they have Appetite - increased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Appetite - increased when taking Methylprednisolone? *

  • female: 70.83 %
  • male: 29.17 %

What is the age of people who have Appetite - increased when taking Methylprednisolone? *

  • 0-1: 0.0 %
  • 2-9: 5.45 %
  • 10-19: 5.45 %
  • 20-29: 7.27 %
  • 30-39: 20.0 %
  • 40-49: 14.55 %
  • 50-59: 20.0 %
  • 60+: 27.27 %

What are other drugs people take besides Methylprednisolone? *

  1. Acetaminophen: 41 people, 46.07%
  2. Prednisone: 41 people, 46.07%
  3. Diphenhydramine Hydrochloride: 23 people, 25.84%
  4. Pantoprazole Sodium: 19 people, 21.35%
  5. Tylenol: 16 people, 17.98%
  6. Mycophenolate Mofetil: 12 people, 13.48%
  7. Metformin: 12 people, 13.48%
  8. Pantoprazole: 11 people, 12.36%
  9. Benadryl: 11 people, 12.36%
  10. Naproxen: 11 people, 12.36%

What are other side effects people have besides Appetite - increased? *

  1. Weight Increased: 41 people, 46.07%
  2. Nausea (feeling of having an urge to vomit): 35 people, 39.33%
  3. Headache (pain in head): 34 people, 38.20%
  4. High Blood Pressure: 34 people, 38.20%
  5. Nausea And Vomiting: 30 people, 33.71%
  6. Weakness: 29 people, 32.58%
  7. Fatigue (feeling of tiredness): 26 people, 29.21%
  8. Infusion Related Reaction: 26 people, 29.21%
  9. Pain: 25 people, 28.09%
  10. Cough: 24 people, 26.97%

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 23 people, 25.84%
  2. Enterococcal Infection: 8 people, 8.99%
  3. Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 7.87%
  4. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 7 people, 7.87%
  5. Generalised Oedema (swelling all over the body): 7 people, 7.87%
  6. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 7 people, 7.87%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 4.49%
  8. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 4 people, 4.49%
  9. Insomnia (sleeplessness): 4 people, 4.49%
  10. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 4.49%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Appetite - increased?

- Check whether Appetite - increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Appetite - increased treatments and more:

How severe was Appetite - increased and when was it recovered:

Expand to all the drugs that have ingredients of methylprednisolone:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - increased:

Browse all the conditions that are associated with Appetite - increased:


How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: